Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • Resident, Medicine, Stanford University, School of Medicine 1990 - 1991
  • Intern, Medicine, Stanford University, School of Medicine 1989 - 1990
  • M.D., Stanford University 1989
• 

  Previous Appointments & Affiliations

  • Associate Professor of Medicine, Medicine, Hematologic Malignancies and Cellular Therapy, Medicine 2015 - 2020
  • Instructor, Temporary in the Department of Medicine, Medicine, Hematologic Malignancies and Cellular Therapy, Medicine 2013 - 2015
• Research
• 

  External Relationships

  • Acepodia
  • ImCheck
  • PhosphoGam, Inc.
• Publications & Artistic Works
• 

  Selected Publications

  • Academic Articles

    • Lew, Meagan V., Yi Ren, Yen P. Lowder, Sharareh Siamakpour-Reihani, Sendhilnathan Ramalingam, Kristi M. Romero, Jillian C. Thompson, et al. “Geriatric Assessment Reveals Actionable Impairments in Hematopoietic Stem Cell Transplantation Candidates Age 18 to 80 Years.” Transplant Cell Ther 28, no. 8 (August 2022): 498.e1-498.e9. https://doi.org/10.1016/j.jtct.2022.05.018.
       Full Text  Link to Item
    • Sung, Anthony D., Vinay K. Giri, Helen Tang, Krista Rowe Nichols, Meagan V. Lew, Lauren Bohannon, Yi Ren, et al. “Home-Based Hematopoietic Cell Transplantation in the United States.” Transplant Cell Ther 28, no. 4 (April 2022): 207.e1-207.e8. https://doi.org/10.1016/j.jtct.2022.01.015.
       Full Text  Link to Item
    • Islam, Prioty, Helen Tang, Haesu Jin, Felicia Cao, Lauren M. Bohannon, Yi Ren, Nelson J. Chao, et al. “Female Sex Is Associated with Improved Long-Term Survival Following Allogeneic Hematopoietic Stem Cell Transplantation.” Transplant Cell Ther 27, no. 9 (September 2021): 784.e1-784.e7. https://doi.org/10.1016/j.jtct.2021.06.012.
       Full Text  Link to Item
    • Bohannon, Lauren, Helen Tang, Kristin Page, Yi Ren, Sin-Ho Jung, Alexandra Artica, Anne Britt, et al. “Decreased Mortality in 1-Year Survivors of Umbilical Cord Blood Transplant vs. Matched Related or Matched Unrelated Donor Transplant in Patients with Hematologic Malignancies.” Transplantation and Cellular Therapy 27, no. 8 (August 2021): 669.e1-669.e8. https://doi.org/10.1016/j.jtct.2021.05.002.
       Full Text  Open Access Copy
    • Pabon, Cindy M., Zhiguo Li, Therese Hennig, Carlos de Castro, Jadee L. Neff, Mitchell E. Horwitz, Thomas W. LeBlanc, et al. “Morphologic leukemia-free state in acute myeloid leukemia is sufficient for successful allogeneic hematopoietic stem cell transplant.” Blood Cancer J 11, no. 5 (May 16, 2021): 92. https://doi.org/10.1038/s41408-021-00481-9.
       Full Text  Open Access Copy  Link to Item
    • Giri, Vinay K., Kristin G. Kegerreis, Yi Ren, Lauren M. Bohannon, Erica Lobaugh-Jin, Julia A. Messina, Anita Matthews, et al. “Chlorhexidine Gluconate Bathing Reduces the Incidence of Bloodstream Infections in Adults Undergoing Inpatient Hematopoietic Cell Transplantation.” Transplant Cell Ther 27, no. 3 (March 2021): 262.e1-262.e11. https://doi.org/10.1016/j.jtct.2021.01.004.
       Full Text  Link to Item
    • Racioppi, Alessandro, Tara Dalton, Sendhilnathan Ramalingam, Kristi Romero, Yi Ren, Lauren Bohannon, Consuelo Arellano, et al. “Assessing the Feasibility of a Novel mHealth App in Hematopoietic Stem Cell Transplant Patients.” Transplant Cell Ther 27, no. 2 (February 2021): 181.e1-181.e9. https://doi.org/10.1016/j.jtct.2020.10.017.
       Full Text  Link to Item
    • Maung, Ko K., Benny J. Chen, Ian Barak, Zhiguo Li, David A. Rizzieri, Cristina Gasparetto, Keith M. Sullivan, et al. “Phase I dose escalation study of naive T-cell depleted donor lymphocyte infusion following allogeneic stem cell transplantation.” Bone Marrow Transplant 56, no. 1 (January 2021): 137–43. https://doi.org/10.1038/s41409-020-0991-5.
       Full Text  Link to Item
    • Ramalingam, Sendhilnathan, Sharareh Siamakpour-Reihani, Lauren Bohannan, Yi Ren, Alexander Sibley, Jeff Sheng, Li Ma, et al. “A phase 2 trial of the somatostatin analog pasireotide to prevent GI toxicity and acute GVHD in allogeneic hematopoietic stem cell transplant.” Plos One 16, no. 6 (January 2021): e0252995. https://doi.org/10.1371/journal.pone.0252995.
       Full Text
    • Smith, Patrick, Jillian C. Thompson, Elena Perea, Brian Wasserman, Lauren Bohannon, Alessandro Racioppi, Taewoong Choi, et al. “Clinical and Neuroimaging Correlates of Post-Transplant Delirium.” Biol Blood Marrow Transplant 26, no. 12 (December 2020): 2323–28. https://doi.org/10.1016/j.bbmt.2020.09.016.
       Full Text  Link to Item
    • Maung, Ko, Sendhilnathan Ramalingam, Mohammad Chaudhry, Yi Ren, Sin-Ho Jung, Kristi Romero, Kelly Corbet, et al. “Pre-transplant hepatic steatosis (fatty liver) is associated with chronic graft-vs-host disease but not mortality.” Plos One 15, no. 9 (2020): e0238824. https://doi.org/10.1371/journal.pone.0238824.
       Full Text  Link to Item
    • Anand, Sarah, Samantha Thomas, Terry Hyslop, Janet Adcock, Kelly Corbet, Cristina Gasparetto, Richard Lopez, et al. “Transplantation of Ex Vivo Expanded Umbilical Cord Blood (NiCord) Decreases Early Infection and Hospitalization.” Biol Blood Marrow Transplant 23, no. 7 (July 2017): 1151–57. https://doi.org/10.1016/j.bbmt.2017.04.001.
       Full Text  Link to Item
    • Sivaraj, Dharshan, Michael M. Green, Zhiguo Li, Anthony D. Sung, Stefanie Sarantopoulos, Yubin Kang, Gwynn D. Long, et al. “Outcomes of Maintenance Therapy with Bortezomib after Autologous Stem Cell Transplantation for Patients with Multiple Myeloma.” Biol Blood Marrow Transplant 23, no. 2 (February 2017): 262–68. https://doi.org/10.1016/j.bbmt.2016.11.010.
       Full Text  Link to Item
    • Bonneville, Marc, Zheng W. Chen, Julie Déchanet-Merville, Matthias Eberl, Jean Jacques Fournié, Julie M. Jameson, Richard D. Lopez, Massimo Massaia, and Bruno Silva-Santos. “Chicago 2014--30 years of γδ T cells.” Cell Immunol 296, no. 1 (July 2015): 3–9. https://doi.org/10.1016/j.cellimm.2014.11.001.
       Full Text  Link to Item
    • Xu, H. -. G., Y. -. X. Zhai, J. Chen, Y. Lu, J. -. W. Wang, C. -. S. Quan, R. -. X. Zhao, et al. “LKB1 reduces ROS-mediated cell damage via activation of p38.” Oncogene 34, no. 29 (July 2015): 3848–59. https://doi.org/10.1038/onc.2014.315.
       Full Text  Link to Item
    • Beck, Benjamin H., Hyunggoon Kim, Rebecca O’Brien, Martin R. Jadus, G Yancey Gillespie, Gretchen A. Cloud, Neil T. Hoa, et al. “Dynamics of Circulating γδ T Cell Activity in an Immunocompetent Mouse Model of High-Grade Glioma.” Plos One 10, no. 5 (2015): e0122387. https://doi.org/10.1371/journal.pone.0122387.
       Full Text  Link to Item
    • Lopez, Richard D. “Inhibiting inhibitory pathways in human γδ T cells.” Blood 122, no. 6 (August 8, 2013): 857–58. https://doi.org/10.1182/blood-2013-06-506584.
       Full Text  Link to Item
    • Lindhorst, Scott M., Richard D. Lopez, and Ronald D. Sanders. “An unusual presentation of chronic myelogenous leukemia: a review of isolated central nervous system relapse.” J Natl Compr Canc Netw 11, no. 7 (July 2013): 745–49. https://doi.org/10.6004/jnccn.2013.0097.
       Full Text  Link to Item
    • Beck, Benjamin, G Yancey Gillespie, Richard D. Lopez, Gretchen A. Cloud, Cathy Langford, Hyung Kim, Lualhati Harkins, and Lawrence S. Lamb. “Abstract 530: Circulating γδ T cells are activated and depleted during progression of high-grade gliomas: Implications for γδ T cells therapy of GBM.” Cancer Research 72, no. 8_Supplement (April 15, 2012): 530–530. https://doi.org/10.1158/1538-7445.am2012-530.
       Full Text
    • Kanda, Junya, Richard D. Lopez, and David A. Rizzieri. “Alemtuzumab for the prevention and treatment of graft-versus-host disease.” Int J Hematol 93, no. 5 (May 2011): 586–93. https://doi.org/10.1007/s12185-011-0802-2.
       Full Text  Link to Item
    • Kanda, J., R. D. Lopez, and D. A. Rizzieri. “Alemtuzumab for the prevention and treatment of graft-versus-host disease.” International Journal of Hematology, 2011, 1–8.
    • Bryant, Nichole L., G Yancey Gillespie, Richard D. Lopez, James M. Markert, Gretchen A. Cloud, Catherine P. Langford, Hilal Arnouk, et al. “Preclinical evaluation of ex vivo expanded/activated γδ T cells for immunotherapy of glioblastoma multiforme.” J Neurooncol 101, no. 2 (January 2011): 179–88. https://doi.org/10.1007/s11060-010-0245-2.
       Full Text  Link to Item
    • Beck, Benjamin H., Hyung-Gyoon Kim, Hyunki Kim, Sharon Samuel, Zhiyong Liu, Robin Shrestha, Hilary Haines, Kurt Zinn, and Richard D. Lopez. “Adoptively transferred ex vivo expanded gammadelta-T cells mediate in vivo antitumor activity in preclinical mouse models of breast cancer.” Breast Cancer Res Treat 122, no. 1 (July 2010): 135–44. https://doi.org/10.1007/s10549-009-0527-6.
       Full Text  Link to Item
    • Bryant, Nichole L., Catalina Suarez-Cuervo, G Yancey Gillespie, James M. Markert, L Burt Nabors, Sreelatha Meleth, Richard D. Lopez, and Lawrence S. Lamb. “Characterization and immunotherapeutic potential of gammadelta T-cells in patients with glioblastoma.” Neuro Oncol 11, no. 4 (August 2009): 357–67. https://doi.org/10.1215/15228517-2008-111.
       Full Text  Link to Item
    • Liu, Zhiyong, Ben Guo, and Richard D. Lopez. “Expression of intercellular adhesion molecule (ICAM)-1 or ICAM-2 is critical in determining sensitivity of pancreatic cancer cells to cytolysis by human gammadelta-T cells: implications in the design of gammadelta-T-cell-based immunotherapies for pancreatic cancer.” J Gastroenterol Hepatol 24, no. 5 (May 2009): 900–911. https://doi.org/10.1111/j.1440-1746.2008.05668.x.
       Full Text  Link to Item
    • Liu, Zhiyong, Isam-Eldin A. Eltoum, Ben Guo, Benjamin H. Beck, Gretchen A. Cloud, and Richard D. Lopez. “Protective immunosurveillance and therapeutic antitumor activity of gammadelta T cells demonstrated in a mouse model of prostate cancer.” J Immunol 180, no. 9 (May 1, 2008): 6044–53. https://doi.org/10.4049/jimmunol.180.9.6044.
       Full Text  Link to Item
    • Suarez-Cuervo, C., N. L. Bryant, R. D. Lopez, G. Y. Gillespie, and L. S. Lamb. “Ex vivo activation and expansion of γδ T cells for immunotherapy of glioblastoma.” J Clin Oncol 24, no. 18_suppl (June 20, 2006): 2553.
       Link to Item
    • Qiu, Wei-Hua, Bing-Sen Zhou, Peiguo-G Chu, Wen-Gang Chen, Christopher Chung, Jennifer Shih, Paul Hwu, Christopher Yeh, Richard Lopez, and Yun Yen. “Over-expression of fibroblast growth factor receptor 3 in human hepatocellular carcinoma.” World J Gastroenterol 11, no. 34 (September 14, 2005): 5266–72. https://doi.org/10.3748/wjg.v11.i34.5266.
       Full Text  Link to Item
    • Guo, Ben L., Zhiyong Liu, Wayne A. Aldrich, and Richard D. Lopez. “Innate anti-breast cancer immunity of apoptosis-resistant human gammadelta-T cells.” Breast Cancer Res Treat 93, no. 2 (September 2005): 169–75. https://doi.org/10.1007/s10549-005-4792-8.
       Full Text  Link to Item
    • Liu, Zhiyong, Ben L. Guo, Bradley C. Gehrs, Li Nan, and Richard D. Lopez. “Ex vivo expanded human Vgamma9Vdelta2+ gammadelta-T cells mediate innate antitumor activity against human prostate cancer cells in vitro.” J Urol 173, no. 5 (May 2005): 1552–56. https://doi.org/10.1097/01.ju.0000154355.45816.0b.
       Full Text  Link to Item
    • Lamb, Lawrence S., and Richard D. Lopez. “gammadelta T cells: a new frontier for immunotherapy?” Biol Blood Marrow Transplant 11, no. 3 (March 2005): 161–68. https://doi.org/10.1016/j.bbmt.2004.11.015.
       Full Text  Link to Item
    • Qiu, Weihua, Bingsen Zhou, Hongzhi Zou, Xiyong Liu, Peiguo G. Chu, Richard Lopez, Jennifer Shih, Christopher Chung, and Yun Yen. “Hypermethylation of growth arrest DNA damage-inducible gene 45 beta promoter in human hepatocellular carcinoma.” Am J Pathol 165, no. 5 (November 2004): 1689–99. https://doi.org/10.1016/s0002-9440(10)63425-6.
       Full Text  Link to Item
    • Qiu, Weihua, Donald David, Bingsen Zhou, Peiguo G. Chu, Bohe Zhang, Mengchao Wu, Jiacheng Xiao, et al. “Down-regulation of growth arrest DNA damage-inducible gene 45beta expression is associated with human hepatocellular carcinoma.” Am J Pathol 162, no. 6 (June 2003): 1961–74. https://doi.org/10.1016/s0002-9440(10)64329-5.
       Full Text  Link to Item
    • Guo, Ben L., Klaus A. Hollmig, and Richard D. Lopez. “Down-regulation of IL-2 receptor alpha (CD25) characterizes human gammadelta-T cells rendered resistant to apoptosis after CD2 engagement in the presence of IL-12.” Cancer Immunol Immunother 50, no. 11 (January 2002): 625–37. https://doi.org/10.1007/s00262-001-0244-4.
       Full Text  Link to Item
    • Lopez, Richard D. “Human gammadelta-T cells in adoptive immunotherapy of malignant and infectious diseases.” Immunol Res 26, no. 1–3 (2002): 207–21. https://doi.org/10.1385/IR:26:1-3:207.
       Full Text  Link to Item
    • Vaughan, W. P., R. O. Katz, D. E. Salzman, A. B. Tilden, R. D. Lopez, A. Garcia, O. Pena, M. Shackelford, and M. H. Carabasi. “MRD allo transplantation using a large volume leukopheresis product mobilized with G-CSF and Decadron, pharmacokinetics directed modest dose intravenous busulfan plus fludarabine conditioning, and long MTX/CSA results in sustained engraftment, low 30 day mortality, and low incidence of severe GVHD.” Blood 98, no. 11 (November 16, 2001): 200A-200A.
       Link to Item
    • Lopez, R. D., E. K. Waller, P. H. Lu, and R. S. Negrin. “CD58/LFA-3 and IL-12 provided by activated monocytes are critical in the in vitro expansion of CD56+ T cells.” Cancer Immunol Immunother 49, no. 12 (February 2001): 629–40. https://doi.org/10.1007/s002620000148.
       Full Text  Link to Item
    • Lopez, R. D., S. Xu, B. Guo, R. S. Negrin, and E. K. Waller. “CD2-mediated IL-12-dependent signals render human gamma delta-T cells resistant to mitogen-induced apoptosis, permitting the large-scale ex vivo expansion of functionally distinct lymphocytes: implications for the development of adoptive immunotherapy strategies.” Blood 96, no. 12 (December 1, 2000): 3827–37.
       Link to Item
    • Sun, Q., R. L. Burton, A. M. Ship, W. P. Vaughan, D. E. Salzman, R. Lopez, M. A. Carabasi, B. Pohlman, and K. G. Lucas. “Adoptive immunotherapy with allogeneic EBV CTL for organ transplant patients with ebv induced lymphoproliferative disease.” Blood 96, no. 11 PART II (December 1, 2000).
    • Barnadas, M. A., S. Brunet, A. Sureda, R. López, R. Curell, J. Sierra, and A. Alomar. “Exuberant granulation tissue associated with chronic graft-versus-host disease after transplantation of peripheral blood progenitor cells.” J Am Acad Dermatol 41, no. 5 Pt 2 (November 1999): 876–79. https://doi.org/10.1016/s0190-9622(99)70350-6.
       Full Text  Link to Item
    • Sherman, M. A., V. H. Secor, S. K. Lee, R. D. Lopez, and M. A. Brown. “STAT6-independent production of IL-4 by mast cells.” Eur J Immunol 29, no. 4 (April 1999): 1235–42. https://doi.org/10.1002/(SICI)1521-4141(199904)29:04<1235::AID-IMMU1235>3.0.CO;2-0.
       Full Text  Link to Item
    • Lopez, R. D., N. Poloso, R. S. Negrin, S. Xu, and E. K. Waller. “Engagement of CD2/LFA-2 on activated human peripheral blood T cells results in an IL-12-dependent resistance to Activation-Induced Cell Death (AICD) in γδ T cells.” Faseb Journal 12, no. 5 (March 20, 1998).
    • Martino, R., R. López, R. Pericas, I. Badell, A. Sureda, and S. Brunet. “Listeriosis in bone marrow transplant recipient.” Clin Infect Dis 23, no. 2 (August 1996): 419–20. https://doi.org/10.1093/clinids/23.2.419.
       Full Text  Link to Item
    • Martino, R., A. Altes, J. Nomdedeu, A. Sureda, S. Brunet, R. Lopez, and A. Domingo Albos. “Atypical presentation of pneumococcal pneumonia in a patient undergoing bone marrow transplantation for Hodgkin's disease.” Bone Marrow Transplant 14, no. 1 (July 1994): 174–75.
       Link to Item
    • Margulies, D. H., R. Lopez, L. F. Boyd, and J. McCluskey. “Engineering soluble major histocompatibility molecules: why and how.” Immunol Res 6, no. 1–2 (1987): 101–16. https://doi.org/10.1007/BF02918107.
       Full Text  Link to Item

  • Conference Papers

    • Smith, Patrick J., Meagan Lew, Yen Lowder, Kristi Romero, Jillian C. Thompson, Lauren Bohannon, Alyssa Pittman, et al. “Cognitive impairment in candidates for allogeneic hematopoietic stem cell transplantation.” In Bone Marrow Transplant, 57:89–94, 2022. https://doi.org/10.1038/s41409-021-01470-z.
       Full Text  Link to Item
    • Lin, Chenyu, Laura Morrison, Edwin Alyea, Taewoong Choi, Cristina Gasparetto, Gwynn Long, Richard Lopez, et al. “Allogeneic Stem Cell Transplantation with Omidubicel: Long-Term Follow-Up from a Single Center.” In Blood, 138:1827–1827. American Society of Hematology, 2021.
       Link to Item
    • Pabon, Cindy M., Zhiguo Li, Therese Hennig, Carlos De Castro, Jadee Neff, Mitchell E. Horwitz, Thomas W. Leblanc, et al. “Morphologic Leukemia-Free State in Acute Myeloid Leukemia Is Sufficient for Successful Allogeneic Hematopoietic Stem Cell Transplant.” In Blood, 136:24–25. American Society of Hematology, 2020. https://doi.org/10.1182/blood-2020-133901.
       Full Text
    • Maung, Ko, Nelson Jen An Chao, Kelly Corbet, Ashley Morris Engemann, Cristina Gasparetto, Mitchell Horwitz, Yubin Kang, et al. “CLO20-049: Retrospective Study of Safety and Toxicity Profile Comparison for Propylene Glycol-Free Melphalan (Evomela®) and Generic Melphalan.” In Journal of the National Comprehensive Cancer Network, 18:CLO20-049. Harborside Press, LLC, 2020. https://doi.org/10.6004/jnccn.2019.7412.
       Full Text
    • Bohannon, Lauren M., Kristin M. Page, Yi Ren, Sin-Ho Jung, Vinay K. Giri, Meagan V. Lew, Matthew Kelly, et al. “Decreased Mortality after the First Year of Allogeneic Hematopoietic Stem Cell Transplant in Recipients of Umbilical Cord Blood Vs. Matched Related or Matched Unrelated Donors.” In Blood, 134:4613–4613. American Society of Hematology, 2019. https://doi.org/10.1182/blood-2019-126906.
       Full Text
    • Giri, Vinay K., Kristin G. Kegerreis, Yi Ren, Lauren M. Bohannon, Erica Lobaugh-Jin, Julia A. Messina, Anita Matthews, et al. “Daily Chlorhexidine Gluconate Bathing Reduces the Rate of Bloodstream Infections in Adults Undergoing Inpatient Hematopoietic Stem Cell Transplantation.” In Blood, 134:2210–2210. American Society of Hematology, 2019. https://doi.org/10.1182/blood-2019-122272.
       Full Text
    • Lew, Meagan V., Yi Ren, Yen P. Lowder, Kristi M. Romero, Jillian C. Thompson, Lauren M. Bohannon, Harvey Cohen, et al. “Geriatric Assessment Identifies Impairments in Younger Candidates for Allogeneic Hematopoietic Stem Cell Transplantation.” In Blood, 134:1984–1984. American Society of Hematology, 2019. https://doi.org/10.1182/blood-2019-127264.
       Full Text
    • Maung, Ko Ko Ko, Mohammad Chaudhry, Yi Ren, Sin-Ho Jung, Kristi M. Romero, Kelly Corbet, Nelson J. Chao, et al. “Pre-Transplant Hepatic Steatosis (fatty liver) Predicts Chronic Graft-Vs-Host Disease but Does Not Affect Mortality.” In Blood, 134:5731–5731. American Society of Hematology, 2019. https://doi.org/10.1182/blood-2019-121830.
       Full Text
    • McManigle, William C., Rachel A. DiCioccio, Sarah Anand, Zhiguo Li, Jonathan C. Poe, Krista R. Nichols, Amy N. Suthers, et al. “Evaluation of the Oral SYK Inhibitor Fostamatinib in Patients after Allogeneic Transplantation for Chronic Graft-Versus-Host Disease.” In Blood, 134:4521–4521. American Society of Hematology, 2019. https://doi.org/10.1182/blood-2019-130742.
       Full Text
    • Anand, Sarah, Samantha Thomas, Kelly Corbet, Cristina Gasparetto, Gwynn D. Long, Richard Lopez, Ashley K. Morris, et al. “Adult Umbilical Cord Blood Transplantation Using Myeloablative Thiotepa, Total Body Irradiation, and Fludarabine Conditioning.” In Biol Blood Marrow Transplant, 23:1949–54, 2017. https://doi.org/10.1016/j.bbmt.2017.06.027.
       Full Text  Link to Item
    • Beck, Benjamin, Richard D. Lopez, G Yancey Gillespie, Hyung Kim, Gretchen Cloud, Larisa Pereboeva, and Lawrence S. Lamb. “Peripheral Blood γδ T Cell Response to High-Grade Glioma: Implications for Localized Adoptive Immunotherapy.” In Blood, 120:4114–4114. American Society of Hematology, 2012. https://doi.org/10.1182/blood.v120.21.4114.4114.
       Full Text
    • Beck, Benjamin, Richard D. Lopez, G Yancey Gillespie, Hyung Kim, Gretchen Cloud, Larisa Pereboeva, and Lawrence S Jr Lamb. “Peripheral Blood gamma delta T Cell Response to High-Grade Glioma: Implications for Localized Adoptive Immunotherapy.” In Blood, Vol. 120, 2012.
       Link to Item
    • Suarez, C., N. L. Bryant, Y. Gillespie, R. D. Lopez, J. M. Markert, and L. S. Lamb. “189: γδ T cells as immunotherapy for glioblastoma multiforme.” In Biology of Blood and Marrow Transplantation, 13:70–70. Elsevier BV, 2007. https://doi.org/10.1016/j.bbmt.2006.12.193.
       Full Text
    • Suarez-Cuervo, C., N. L. Bryant, R. D. Lopez, G. Y. Gillespie, and L. S. Lamb. “Ex vivo activation and expansion of gamma delta T cells for immunotherapy of glioblastorna.” In Journal of Clinical Oncology, 24:113S-113S. AMER SOC CLINICAL ONCOLOGY, 2006.
       Link to Item
    • Gehrs, B. C., and R. D. Lopez. “Ex vivo expansion of gamma delta-T lymphocytes from melanoma patients and healthy control donors.” In Transfusion, 45:8A-8A. BLACKWELL PUBLISHING, 2005.
       Link to Item

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.